NCT05470569 Argentinian Prospective Registry of Patients With Lupus
| NCT ID | NCT05470569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sociedad Argentina de Reumatologia |
| Condition | SLE |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2023-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2022-04-01 with a primary completion date of 2023-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In Latin America, information about patients with systemic lupus erythematosus (SLE) is limited. Multicenter studies are needed to obtain "real world data '' and to carry out longer follow-ups. The purpose of this project is to design a cohort of Argentinian patients with SLE to describe "our real setting" and to identify possible limitations in access to specialized consultations and treatments.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 18 years of age * Classified as SLE (according to the 1982/1997 American College of Rheumatology criteria and/or Systemic Lupus International Collaborating Clinics criteria for SLE) * Less than 5 years from meeting SLE criteria * Informed consent signature Exclusion Criteria: * Diagnosis of other systemic autoimmune diseases or overlap syndromes * Patients who have been transferred to other centers
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05470569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying SLE. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05470569 currently recruiting?
Yes, NCT05470569 is actively recruiting participants. Contact the research team at unisar@reumatologia.org.ar for enrollment information.
Where is the NCT05470569 trial being conducted?
This trial is being conducted at La Plata, Argentina.
Who is sponsoring the NCT05470569 clinical trial?
NCT05470569 is sponsored by Sociedad Argentina de Reumatologia. The trial plans to enroll 1,500 participants.